About this trial
Osteogenesis Imperfecta (OI) is a rare disorder of increased bone fragility characterized by fractures with minimal or absent trauma, dentinogenesis imperfecta (DI), and, in adult years, hearing loss. It is seen in both genders and all races. The clinical features of OI represent a continuum varying from perinatal lethality to individuals with severe skeletal deformities, mobility impairments, and very short stature to nearly asymptomatic individuals with a mild predisposition to fractures, normal stature, and normal lifespan. Fractures can occur in any bone, but are most common in the extremities. These disorders can be devastating and progressive and result in deformity, chronic pain, impaired function and loss of quality of life.
The overall goal of this study is to answer specific question about the natural history of brittle bone diseases as defined by molecular etiology and to develop the foundation for prospective clinical studies.
Eligibility criteria
Qualifiers
Individuals with OI diagnosed by molecular (DNA) analysis OR
Individuals whose clinical history and radiographs are highly suggestive of OI, but whose diagnosis has not been verified by biochemical or molecular studies
Disqualifiers
Individuals who are unable to return for their scheduled follow up visits.
Individuals with skeletal dysplasias other than OI
Individuals with OI and a second genetic or syndromic diagnosis
Use of a bone-acting treatment agent such as bisphosphonates, calcitonin, calcitriol, fluoride, etc., within one year of enrollment.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Sponsors and collaborators
Baylor College of Medicine
Lead sponsor
Shriners Hospitals for Children
Collaborator
Hospital for Special Surgery, New York
Collaborator
Children's National Research Institute
Collaborator
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
Collaborator
University of California, Los Angeles
Collaborator
Oregon Health and Science University
Collaborator
University of Nebraska
Collaborator
Alfred I. duPont Hospital for Children
Collaborator
University of South Florida
Collaborator
Phoenix Children's Hospital
Collaborator
Marquette University
Collaborator